A 5‐Year Survey on Multiple Targeted Benzimidazole Hybrids
Authors:
- 5 November 2025
- journal article
- review article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (1) , e00769
Abstract
Among heterocyclic compounds, the various biological activities and the easily modifiable chemical structure of benzimidazole compounds make them important in drug development. Currently, the demand for treatments targeting multiple biological pathways is increasing. In the treatment of multifaceted diseases, drugs exhibiting multiple therapeutic effects and low toxicity are particularly advantageous. In this context, the ability of benzimidazole compounds to form hybrid structures that target multiple biological mechanisms is noteworthy. In this review, studies on the multifaceted biological activities of hybrid benzimidazole derivatives—including benzimidazole–triazole, benzimidazole–thiazole, benzimidazole–oxadiazole, benzimidazole–quinoline, benzimidazole–hydrazone, benzimidazole‐benzimidazole, benzimidazole–thiadiazole, benzimidazole–piperazine, benzimidazole‐imidazole, benzimidazole‐benzothiazole, benzimidazole–coumarin, benzimidazole–indole, benzimidazole‐Schiff base and benzimidazole‐urea reported in the literature over the past 5 years are discussed. In addition, this review also examines molecular modeling and structure–activity relationship studies to elucidate their therapeutic potential, highlighting the contribution of hybrid benzimidazole derivatives to the development of effective drugs.Keywords
This publication has 57 references indexed in Scilit:
- In Vitro and In Silico Evaluation of Anticancer Potential and Apoptotic Activity of Benzimidazole‐Based CompoundsChemistrySelect, 2025
- Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activityArchiv der Pharmazie, 2024
- Recent development and strategies towards target interactions: Synthesis, characterization and in silico analysis of benzimidazole based thiadiazole as potential anti-Alzheimer agentsBiochemical and Biophysical Research Communications, 2024
- Benzimidazole-oxindole hybrids as multi-kinase inhibitors targeting melanomaBioorganic Chemistry, 2024
- Synthesis, molecular docking and ADMET studies of bis-benzimidazole-based thiadiazole derivatives as potent inhibitors, in vitro α-amylase and α-glucosidaseArabian Journal of Chemistry, 2023
- Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicineActa Pharmaceutica Sinica B, 2022
- Antioxidant and DNA damage protecting activities of newly synthesized thiol bridged bis‐benzimidazole derivative and its dicationic analogueJournal of Heterocyclic Chemistry, 2020
- Design, synthesis and anticancer/antiestrogenic activities of novel indole-benzimidazolesBioorganic Chemistry, 2020
- Synthesis of novel tetra‐substituted benzimidazole compounds containing certain heterostructures with antioxidant and anti‐urease activitiesJournal of Heterocyclic Chemistry, 2020
- The therapeutic journey of benzimidazoles: A reviewBioorganic & Medicinal Chemistry, 2012